| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,126 |
1,668 |
$103K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,346 |
1,110 |
$102K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
330 |
294 |
$21K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
192 |
165 |
$14K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
142 |
88 |
$11K |
| 96127 |
|
327 |
181 |
$8K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
156 |
132 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
361 |
287 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
129 |
103 |
$4K |
| 99401 |
|
155 |
145 |
$4K |
| 87428 |
|
62 |
57 |
$4K |
| 90686 |
|
417 |
376 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
127 |
100 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
33 |
25 |
$3K |
| 90656 |
|
68 |
62 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
18 |
17 |
$635.94 |
| 87807 |
|
35 |
31 |
$352.10 |
| 90670 |
|
25 |
25 |
$153.60 |
| 99406 |
|
38 |
30 |
$97.50 |
| 99072 |
|
44 |
42 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
30 |
25 |
$0.00 |
| 87081 |
|
65 |
56 |
$0.00 |
| 1036F |
|
33 |
28 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16 |
12 |
$0.00 |